CRUK Convergence Science Centre

The Cancer Research UK Convergence Science Centre supports infrastructure capabilities to address bottlenecks and facilitate translational research. It is our pleasure to introduce to you two of our facilities: The Microfabrication and Prototyping Facility and the Human Organoid Facility and Biobank.

Please join us for a special seminar on Thursday 29th September, from 15.00-16.00, to learn more about what these facilities can do for your research and hear from our experts Dr Sam Au, Dr Florent Seichepine and Dr Simon Tupin (Microfabrication & Prototyping) and Professor Axel Behrens and Dr Sudeep Bhushal (Human Organoid).


The Microfabrication & Prototyping Facility: Dr Sam Au, Dr Florent Seichepine and Dr Simon Tupin – Department of Bioengineering, Imperial College London

Moving past the well plate: Microfabrication made easy for organoids and convergence cancer science

 Microscale platforms including lab-on-chip, organ-on-chip and tumour-on-chip devices may provide superior physiological environments for studying cancer biology and developing therapies. In this talk, the staff of the CRUK Microfabrication & Prototyping Facility will briefly introduce some case studies where microfabrication techniques have been used effectively in the areas of organoids, organ-on-chip devices and interfacing with animal models. We will then highlight the equipment, expertise and technical support on offer and how easily and affordable it is for your groups to access the Facility.




The Human Organoid Facility & Biobank: Dr Sudeep Bhushal – CRUK Convergence Science Centre

 3D organoid culture : A new window into development and disease

 Organoids are in-vitro 3D cellular models derived from primary tissue or stem cells that faithfully recapitulate key elements of the tissue of origin. Organoids are revolutionizing in vitro cell culture as they are accessible, physiologically relevant, and stable system for extended cultivation. However, there are several factors that still restricting their widespread application as novel models for cancer research. In this talk, I will elaborate on the CRUK Organoid Facility and Biobank’s aim to develop new methodologies and technologies to maximise the potential of organoids for cancer research via interdisciplinary, cross-institution, collaborations.



To receive information about how to access this event please email

Please note: This webinar is exclusively available only to colleagues across the Institute of Cancer Research, Imperial College London, the Royal Marsden Hospital and Imperial College Healthcare.